The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2012-03, Vol.155 (2), p.316-318
Hauptverfasser:	Isma'eel, Hussain, Mohanna, Zeina, Hamadeh, Ghassan, Alam, Elie, Badr, Kamal, Alam, Samir, Rebeiz, Abdallah
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Cardiology. Vascular system Cardiovascular Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Cost Developing Countries - economics Developing Countries - statistics & numerical data Drug Costs - statistics & numerical data Health Care Costs - statistics & numerical data Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Medical sciences Middle East - epidemiology Prevention Primary Statin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!